Blue Lake Biotechnology, Inc. — Form D
Blue Lake Biotechnology, Inc. of ATHENS, GA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-08. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-08
- Form: D
- Accession: 0001802857-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 1
- Date of first sale: 2022-04-09
- Revenue range: Decline to Disclose
- SEC file number: 021-464228
Issuer
- Name: Blue Lake Biotechnology, Inc.
- CIK: 0001802857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 111 RIVERBEND ROAD, ATHENS, GA, 30602
- Phone: 706-201-8820
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Biao He | Director | San Francisco, CA |
| Yuan Lin | Director | Athens, GA |
| Ji Ma | Director | Athens, GA |
| Fred Quinn | Director | Athens, GA |
| Biao He | Executive Officer | San Francisco, CA |
| Biao He | Promoter | San Francisco, CA |
| Jixiang An | Director | Athens, GA |
Other filings by this issuer (2)
More